Suppr超能文献

局部晚期右半结肠癌的长期结局及预后因素:一项回顾性队列研究。

The long-term outcomes and prognostic factors about locally advanced right colon cancer: a retrospective cohort study.

作者信息

Li Changzheng, Li Zhenyu, Zhang Jiachen, Zhang Xijie, Wei Matthew Yuan-Kun, Teo Nan Zun, Ma Pengfei, Zhang Junli, Li Sen, Li Zhi, Zhao Yuzhou

机构信息

Department of General Surgery, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.

Department of General Surgery, Lanzhou University Second Hospital, Lanzhou, China.

出版信息

J Gastrointest Oncol. 2024 Feb 29;15(1):250-259. doi: 10.21037/jgo-23-928. Epub 2024 Jan 24.

Abstract

BACKGROUND

The first case of treatment with right hemicolectomy with pancreatoduodenectomy (RHCPD) for locally advanced right-sided colon cancer (LARCC) invading the pancreas, duodenum, or other organs, was reported in 1953 by Van Prohaska. Right-sided colon cancers invading the pancreas and duodenum are rare. Surgery can be technically challenging, with unclear oncologic consequences, hence there are few reports on the clinical outcomes and factors associated with survival in this patient cohort. The need for neoadjuvant chemotherapy in patients with LARCC is controversial, and the long-term survival of these patients as well as the preferred treatment regimen needs to be explored. This paper reports our experience in right hemicolectomy with resection for LARCC. We conducted this study to analyze the clinical features and surgical outcomes of LARCC.

METHODS

A retrospective study was performed using a database of all patients who underwent RHCPD due to the tumour directly invading the duodenum and/or pancreas in a 19-year period [2003-2022]. We included patients whose primary tumor site was the right hemicolon and who had undergone a negative tumor resection margin (R0) resection. In addition, the adhesions between the colon and other organs in these patients were malignant adhesions. The primary outcome was the overall survival after surgery. The secondary endpoints of the study included 30-day postoperative mortality, postoperative complications, prognostic factors, and tumour genetics. All patients were followed up with postoperative imaging at an interval of 3 months for the first 3 years and at an interval of 6 months for the next 2 years, and annual follow-up thereafter. Survival was estimated using Kaplan-Meier analysis. Variables with P values <0.05 in univariate analysis were entered into multivariate Cox proportional risk regression to identify independent predictors of survival.

RESULTS

There were 47 patients (23 males and 24 females) who underwent resection for LARCC. The median age of the patients was 61 years (range, 38-80 years). R0 resection was achieved in all cases. The overall complication rate was 27.7% (n=13). Two patients died within 30 days of surgery. The overall survival was 80.9%, 63.5%, and 51.7% at 1, 3, and 5 years, respectively. Univariate survival analysis identified pancreatic invasion, regional lymph node positivity, more than two organs invaded, and no neoadjuvant treatment as predictors of poor survival (log-rank P<0.05). Multivariate analysis showed that regional lymph node positivity [95% confidence interval (CI): 1.145-7.736; P=0.025] and more than two organs invaded (95% CI: 1.321-26.981; P=0.020) were predictors of poor survival.

CONCLUSIONS

Relatively optimistic clinical outcomes from resection were demonstrated for patients with LARCC. For LARCC patients, resection can be carefully considered.

摘要

背景

1953年,范·普罗哈斯卡报道了首例采用右半结肠切除术联合胰十二指肠切除术(RHCPD)治疗侵犯胰腺、十二指肠或其他器官的局部晚期右侧结肠癌(LARCC)。侵犯胰腺和十二指肠的右侧结肠癌较为罕见。手术在技术上可能具有挑战性,肿瘤学后果尚不明确,因此关于该患者群体的临床结局及生存相关因素的报道较少。LARCC患者是否需要新辅助化疗存在争议,需要探索这些患者的长期生存情况以及首选治疗方案。本文报告了我们采用右半结肠切除术治疗LARCC的经验。我们开展这项研究以分析LARCC的临床特征和手术结局。

方法

采用回顾性研究,利用一个数据库,该数据库包含在19年期间(2003 - 2022年)因肿瘤直接侵犯十二指肠和/或胰腺而接受RHCPD的所有患者。我们纳入了原发肿瘤部位为右半结肠且肿瘤切除切缘阴性(R0)的患者。此外,这些患者结肠与其他器官之间的粘连为恶性粘连。主要结局是术后总生存。该研究的次要终点包括术后30天死亡率、术后并发症、预后因素和肿瘤遗传学。所有患者术后前3年每3个月进行一次影像学随访,接下来2年每6个月进行一次随访,此后每年随访一次。采用Kaplan-Meier分析估计生存情况。单因素分析中P值<0.05的变量纳入多因素Cox比例风险回归,以确定生存的独立预测因素。

结果

有47例患者(23例男性和24例女性)接受了LARCC切除术。患者的中位年龄为61岁(范围38 - 80岁)。所有病例均实现R0切除。总体并发症发生率为27.7%(n = 13)。2例患者在术后30天内死亡。1年、3年和5年的总生存率分别为80.9%、63.5%和51.7%。单因素生存分析确定胰腺侵犯、区域淋巴结阳性、侵犯超过两个器官以及未接受新辅助治疗是生存不良的预测因素(对数秩检验P<0.05)。多因素分析显示,区域淋巴结阳性[95%置信区间(CI):1.145 - 7.736;P = 0.025]和侵犯超过两个器官(95% CI:1.321 - 26.981;P = 0.020)是生存不良的预测因素。

结论

LARCC患者接受切除术可获得相对乐观的临床结局。对于LARCC患者,可谨慎考虑切除术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d5/10932648/ad3b3a733990/jgo-15-01-250-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验